Assignee
SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD
CN·8 granted patents·6 pending applications·20 citations·filing 2016–2023
Top patents by PatentIndex Score
14 records- 0190US11208484B2Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancersSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2017·Granted Dec 28, 2021·4 cites·9 claims
- 0289US11866500B2Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancersSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2021·Granted Jan 9, 2024·1 cites·17 claims
- 0389US10786567B2Stable anti-PD-1 antibody pharmaceutical preparation and application thereof in medicineSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Sep 29, 2020·4 cites·18 claims
- 0487US10543284B2Anti-c-Met antibody and anti-c-Met antibody-cytotoxic drug conjugate and pharmaceutical use thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Jan 28, 2020·6 cites·36 claims
- 0586US11365255B2PD-1 antibody, antigen-binding fragment thereof, and medical application thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2019·Granted Jun 21, 2022·2 cites·12 claims
- 0683US10815304B2PD-L1 antibody, antigen-binding fragment thereof and medical application thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Oct 27, 2020·3 cites·25 claims
- 0782US12435144B2Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancersSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2023·Granted Oct 7, 2025·0 cites·19 claims
- 0859US11780923B2PD-L1 antibody, antigen-binding fragment thereof and medical application thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2020·Granted Oct 10, 2023·0 cites·23 claims
- 0959US2021000954A1Stable anti-pd-1 antibody pharmaceutical preparation and application thereof in medicineSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 1056US2026092031A1Method for preparing 2-hydroxyethyl aminocaproate compound and use thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1155US2024217974A1Isoquinolone compound and use thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1253US2023108572A1Method For Treating Cholesterol-Related DiseasesSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1344US2020054764A1Medical use of anti-c met antibody-cytotoxic drug conjugateSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2017·Application pending·0 cites
- 1443US2021206720A1Method for preparing alkynyl pyridine prolyl hydroxylase inhibitorSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →